ST Shenhua Co., Ltd.

Management Measures for Investor Relations of Shenyang Chemical Co., Ltd.

Shenyang Chemical Co., Ltd. has established "Management Measures for Investor Relations" to regulate communication with investors. The purpose is to enhance investor understanding, improve market visibility, and protect small and medium-sized investors' rights. Key aspects include disclosing development strategy, financial information, and ESG data. The company will establish a dedicated team and a two-way communication mechanism to gather feedback and foster interaction, ensuring honesty and confidentiality.

Announcement by Shenyang Chemical Co., Ltd. on the 2025 Annual Performance Briefing

Shenyang Chemical Co., Ltd. will host an online briefing on April 10, 2026, to discuss its 2025 annual performance and operational status. Investors are invited to participate and submit questions in advance through the provided website or QR code. The company aims to engage with stakeholders and provide insights into its financial results and business activities for the year 2025.

Announcement of Shenyang Chemical Co., Ltd. on the 2026 Investment Plan

Shenyang Chemical Co., Ltd. announced its 2026 investment plan, approved by its Board of Directors. The company plans to invest approximately 241.11 million yuan, focusing on system upgrades and other projects. This strategic investment aims to expand economic capacity, enhance operational safety, and improve efficiency, aligning with the company's development goals.

2025 Environmental, Social, and Governance (ESG) Report of Shenyang Chemical Co., Ltd.

Announcement of Shenyang Chemical Co., Ltd. on Provision for Asset Impairment for 2025

Shenyang Chemical Co., Ltd. announced its provision for asset impairment for 2025, totaling 4,017.34 million yuan. This includes a credit impairment loss of 18.50 million yuan and an asset impairment loss of 4,035.84 million yuan, primarily from inventory and construction in progress. The provision is based on an evaluation as of December 31, 2025, and aims to improve financial reporting accuracy. The Board of Directors and Audit Committee have approved the provision, which will reduce the company's 2025 net profit.

Supplementary Announcement on Adjusting 2025 Annual Routine Related Transactions by Shenyang Chemical Co., Ltd.

Shenyang Chemical Co., Ltd. is adjusting its 2025 annual routine related transactions, primarily involving raw material procurement and labor services with China National Chemical Corporation and its subsidiaries. The projected total transaction amount has significantly increased from an initial 287,442.79 million yuan to a revised 354,720.25 million yuan. The adjusted total for these transactions is 2,596,000 million yuan, with the latest amount as of December 31, 2025, standing at 2,558,512 million yuan. Independent directors have reviewed and approved these adjustments, deeming them beneficial and not harmful to shareholder interests.

Notice of Shenyang Chemical Co., Ltd. Annual Shareholders Meeting for 2025